Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clarithromycin for Septic Syndrome in VAP
NCT00297674Phase 4Completed
- Sponsor
- National and Kapodistrian University of Athens
- Start
- Jun 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in sepsis and ventilator-associated pneumonia (VAP) comparing Clarithromycin with Placebo (2 arms). Primary endpoints: Estimation of crude mortality by any reason, Estimation of attributable mortality by VAP and 6 more. Started Jun 2004; status: completed.
02
Drugs
clarithromycin
03
Conditions
sepsisventilator-associated pneumonia (VAP)
Beyond the preview
Go deeper on NCT00297674.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00297674.